Literature DB >> 28912260

Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.

Teruhiko Imamura1, Ben Chung1, Ann Nguyen1, Daniel Rodgers1, Gabriel Sayer1, Sirtaz Adatya1, Nitasha Sarswat1, Gene Kim1, Jayant Raikhelkar1, Takeyohi Ota1, Tae Song1, Colleen Juricek1, Viktoriya Kagan1, Valluvan Jeevanandam1, Mandeep Mehra1, Daniel Burkhoff1, Nir Uriel2.   

Abstract

BACKGROUND: A cohort of heart failure (HF) patients receiving left ventricular assist devices (LVADs) has decoupling of their diastolic pulmonary artery pressure and pulmonary capillary wedge pressure. However, the clinical implications of this decoupling remain unclear. METHODS AND
RESULTS: In this prospective study, patients with LVADs underwent routine invasive hemodynamic ramp testing with right heart catheterization, during which LVAD speeds were adjusted. Inappropriate decoupling was defined as a >5 mm Hg difference between diastolic pulmonary artery pressure and pulmonary capillary wedge pressure. The primary outcomes of survival and heart failure readmission rates after ramp testing were assessed. Among 63 LVAD patients (60±12 years old and 25 female [40%]), 27 patients (43%) had inappropriate decoupling at their baseline speed. After adjustment of their rotation speed during ramp testing, 30 patients (48%) had inappropriate decoupling. Uni/multivariable Cox analyses demonstrated that decoupling was the only significant predictor for the composite end point of death and heart failure readmission during the 1 year following the ramp study (total of 18 events; hazards ratio, 1.09; 95% confidence interval, 1.04-1.24; P<0.05). Furthermore, normalization of decoupling (n=8) during ramp testing was significantly associated with higher 1-year heart failure readmission-free survival rate compared with the non-normalized group (n=19, 100% versus 53%; P=0.035).
CONCLUSIONS: The presence of inappropriate decoupling was associated with worse outcomes in patients with LVADs. Prospective, large-scale multicenter studies to validate the result are warranted.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  heart failure; hemodynamics; pulmonary artery; survival rate

Mesh:

Year:  2017        PMID: 28912260      PMCID: PMC5745161          DOI: 10.1161/CIRCHEARTFAILURE.117.003882

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  16 in total

Review 1.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

2.  Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

Authors:  Jerry D Estep; Randall C Starling; Douglas A Horstmanshof; Carmelo A Milano; Craig H Selzman; Keyur B Shah; Matthias Loebe; Nader Moazami; James W Long; Josef Stehlik; Vigneshwar Kasirajan; Donald C Haas; John B O'Connell; Andrew J Boyle; David J Farrar; Joseph G Rogers
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

Review 3.  Challenges faced in long term ventricular assist device support.

Authors:  Hirohisa Ikegami; Paul Kurlansky; Koji Takeda; Yoshifumi Naka
Journal:  Expert Rev Med Devices       Date:  2016-07-14       Impact factor: 3.166

4.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

Authors:  William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav
Journal:  Lancet       Date:  2011-02-19       Impact factor: 79.321

Review 5.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

6.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

7.  Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.

Authors:  Ryan J Tedford; Claude A Beaty; Stephen C Mathai; Todd M Kolb; Rachel Damico; Paul M Hassoun; Peter J Leary; David A Kass; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2013-11-28       Impact factor: 10.247

8.  Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor.

Authors:  Raymond L Benza; Amresh Raina; William T Abraham; Philip B Adamson; JoAnn Lindenfeld; Alan B Miller; Robert C Bourge; Jordan Bauman; Jay Yadav
Journal:  J Heart Lung Transplant       Date:  2014-05-10       Impact factor: 10.247

9.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

10.  PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.

Authors:  Ryan J Tedford; Anna R Hemnes; Stuart D Russell; Ilan S Wittstein; Mobusher Mahmud; Ari L Zaiman; Stephen C Mathai; David R Thiemann; Paul M Hassoun; Reda E Girgis; Jonathan B Orens; Ashish S Shah; David Yuh; John V Conte; Hunter C Champion
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790

View more
  15 in total

1.  HVAD Flow Waveform Estimates Left Ventricular Filling Pressure.

Authors:  Teruhiko Imamura; Nikhil Narang; Daniel Rodgers; Daisuke Nitta; Jonathan Grinstein; Takeo Fujino; Gene Kim; Ann Nguyen; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2020-01-23       Impact factor: 5.712

Review 2.  Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.

Authors:  Sriram D Rao; Jonathan N Menachem; Edo Y Birati; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 3.  Clinical implications of hemodynamic assessment during left ventricular assist device therapy.

Authors:  Teruhiko Imamura; Ben Chung; Ann Nguyen; Gabriel Sayer; Nir Uriel
Journal:  J Cardiol       Date:  2017-12-26       Impact factor: 3.159

4.  HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump.

Authors:  Jonathan Grinstein; Daniel Rodgers; Sara Kalantari; Gabriel Sayer; Gene H Kim; Nitasha Sarswat; Sirtaz Adatya; Takeyoshi Ota; Valluvan Jeevanandam; Daniel Burkhoff; Nir Uriel
Journal:  ASAIO J       Date:  2018 Jan/Feb       Impact factor: 2.872

5.  Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.

Authors:  Teruhiko Imamura; Valluvan Jeevanandam; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Bryan Smith; Daniel Rodgers; Stephanie Besser; Ben Chung; Ann Nguyen; Nikhil Narang; Takeyoshi Ota; Tae Song; Colleen Juricek; Mandeep Mehra; Maria Rosa Costanzo; Ulrich P Jorde; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  Circ Heart Fail       Date:  2019-02       Impact factor: 8.790

6.  Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.

Authors:  Teruhiko Imamura; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Bryan Smith; Daniel Rodgers; Ben Chung; Ann Nguyen; Takeyoshi Ota; Tae Song; Colleen Juricek; Valluvan Jeevanandam; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2018-08-10       Impact factor: 5.712

7.  Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; Robin Ruthazer; David Denofrio; Amanda R Vest; David Kent; Michael S Kiernan
Journal:  J Card Fail       Date:  2021-01-12       Impact factor: 5.712

8.  Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation.

Authors:  Teruhiko Imamura; Jerry Nnanabu; Daniel Rodgers; Jayant Raikehlkar; Sara Kalantar; Bryan Smith; Ann Nguyen; Ben Chung; Nikhil Narang; Takeyoshi Ota; Tae Song; Daniel Burkhoff; Valluvan Jeevanandam; Gene Kim; Gabriel Sayer; Nir Uriel
Journal:  ASAIO J       Date:  2020-04       Impact factor: 3.826

9.  Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients.

Authors:  Teruhiko Imamura; Joshua D Moss; Erin Flatley; Daniel Rodgers; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Ann Nguyen; Colleen Juricek; Daniel Burkhoff; Tae Song; Takeyoshi Ota; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  ASAIO J       Date:  2020-01       Impact factor: 3.826

10.  Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events.

Authors:  Teruhiko Imamura; Ann Nguyen; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Bryan Smith; Colleen Juricek; Daniel Rodgers; Takeyoshi Ota; Tae Song; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  Eur J Heart Fail       Date:  2018-12-28       Impact factor: 17.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.